0
Skip to Content
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
About RRP
English
DONATE
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
About RRP
English
DONATE
Folder: For Patients
Back
Folder: For Researchers
Back
Folder: For Clinicians
Back
Folder: Take Action
Back
Folder: About RRP
Back
English
Back
DONATE
  • Medical Education Webinars,
  • Patient Videos & Webinars,
• 8/7/24

2021 RUNX1 Week Keynote Speaker: Dr. David Fajgenbaum

Dr. David Fajgenbaum, co-founder and CEO of the Castleman Disease Collaborative Network, discusses his personal battle with this rare disease that almost killed him several times, and his tireless research that led to the discovery of a life-saving treatment for himself and many other Castleman patients.

Previous

Crosstalk Between Transcription Factors, Methyltransferases and Tyrosine Kinases

Next

Inherited Thrombocytopenia (ITP): What Is It, Whom To Test and How To Test?

You Might Also Like

Related Embedded Video Item Thumbnail Hereditary Hematologic Malignancies: Not That Rare - Emerging Research and Clinical Implications
Related Embedded Video Item Thumbnail Part 1: April 2025 Low-Dose Sirolimus Study Overview with Dr. Courtney DiNardo
Related Embedded Video Item Thumbnail Module 3: The Potential Promise and Current Challenges of Gene Editing
Related Embedded Video Item Thumbnail Transcription Factor Associations Fine-Tune Expression of the RUNX1 Gene Network to Confer Regulatory Logic to Hematopoietic Gene Expression Programs
Related Embedded Video Item Thumbnail 2024 X-Out Cancer Workshop

Get the Latest RUNX1-FPD News

Sign up to receive our newsletter and community updates.

Stay In Touch

Email RRP

Newsletter

Policies

Privacy Policy

Cookie Policy

Accessibility Statement

Site Resources

News & Updates

Calendar of Events

RRP Blog

DONATE
SHOP